Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy-Reference-Cited by-同舟云学术

Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy

Published:2015-01 Issue:1 Volume:51 Page:18-26
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ruff Paul,Ferry David R.,Lakomỳ Radek,Prausová Jana,Van Hazel Guy A.,Hoff Paulo M.,Cunningham David,Arnold Dirk,Schmoll Hans J.,Moiseyenko Vladimir M.,McKendrick Joseph J.,ten Tije Albert J.,Vishwanath Raghu L.,Bhargava Pankaj^ORCID,Chevalier Soazig,Macarulla Teresa,Van Cutsem Eric

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer;Goldberg;J Clin Oncol,2004

2. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group;Saltz;N Engl J Med,2000

3. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study;Tournigand;J Clin Oncol,2004

4. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

5. The continuum of care: a paradigm for the management of metastatic colorectal cancer;Goldberg;Oncologist,2007

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective, Observational Study of Aflibercept Use in Combination with FOLFIRI in Patients with Metastatic Colorectal Cancer: A Real-World Effectiveness Study;Cancers;2024-05-24

2. Gastrointestinal Malignancy: Genetic Implications to Clinical Applications;Cancer Treatment and Research;2024

3. A systemic review and meta-analysis of Aflibercept plus FOLFIRI regimen as a second-line treatment for metastatic colorectal cancer: A PRISMA compliant pooled analysis of randomized controlled trials and single arm studies to assess efficacy and safety;Critical Reviews in Oncology/Hematology;2023-08

4. Clinical outcomes of chemotherapy-based therapies for previously treated advanced colorectal cancer: a systematic literature review and meta-analysis;International Journal of Colorectal Disease;2023-01-11

5. Evidence-Based Second-Line Treatment in RAS Wild-Type/Mutated Metastatic Colorectal Cancer in the Precision Medicine Era;International Journal of Molecular Sciences;2021-07-19